Effect of different feeding approaches on growth, neonatal morbidities, mortality and neurodevelopmental outcome in preterm infants: a systematic review and network meta-analysis
Authors:
- Naema HamoudaNHNaema Hamouda
- Yosra AboEL-AzmYAYosra AboEL-Azm
- Kholoud ElsammanKEKholoud Elsamman
- Soha NabilSNSoha Nabil
- Mohammed TarekMTMohammed Tarek
- Fatma Elzahraa WasiaFWFatma Elzahraa Wasia
- Ahmed Mostafa AminAAAhmed Mostafa Amin
- Ahmed ElshahatAEAhmed Elshahat
- Nourhan HassanNHNourhan Hassan
- Ammar MektebiAMAmmar Mektebi
- Abdelazem KhaledAKAbdelazem Khaled
- Hatim Nasruldin ShahinHSHatim Nasruldin Shahin
- 19 January 2026
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 111 (4) , F352-F359
Abstract
Objective: To compare feeding strategies on preterm infants’ growth during hospitalisation, neonatal morbidities, mortality and neurodevelopmental outcome (NDO) at 18–26 months corrected age. Methods: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension statement for network meta-analysis . We searched five medical databases for randomised controlled trials comparing different feeding approaches in preterm infants and their effects on growth, neonatal morbidities, mortality and NDO. The Cochrane Collaboration’s tool was used to assess the risk of bias. We used a random-effects model. Pooled mean differences (MD) or risk ratios with 95% CIs were calculated. Results: Ninety-five studies (9663 infants) were included. Human milk (HM) with bovine milk fortifier (BMF) (adjusted according to blood urea nitrogen) achieved the best length increment (MD=0.56 cm/week; 95% CI 0.19 to 0.93). Notably, HM+BMF (3.5 gm/kg/d protein) showed the best head circumference growth (MD 0.46 cm/week; 95% CI 0.10 to 0.81) but no significant difference in weight gain. There were no significant differences in neonatal morbidities/mortality. While MOM|+PTF (supp) displayed significantly lower NDO delay in the domain of mild cognitive delay. Conclusion: Overall, there is a lack of strong evidence to support a specific enteral feeding strategy and further high-quality research is required. Targeted HM fortification appears to improve head growth, while adjusted fortification enhances length. Given the significant inconsistency detected, which may compromise the reliability of the network estimates, these results must be interpreted carefully.Keywords
This publication has 100 references indexed in Scilit:
- Powdered human milk‐derived versus bovine milk‐derived breastmilk fortification: A multi‐centre preterm randomised controlled trialJournal of Pediatric Gastroenterology and Nutrition, 2024
- Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant FormulaJAMA, 2024
- Fortification of Breast Milk With Preterm Formula Powder vs Human Milk Fortifier in Preterm NeonatesJAMA Pediatrics, 2021
- Multi-nutrient fortification of human milk for preterm infantsCochrane Database of Systematic Reviews, 2020
- Effects of Targeted Versus Adjustable Protein Fortification of Breast Milk on Early Growth in Very Low‐Birth‐Weight Preterm Infants: A Randomized Clinical TrialNutrition in Clinical Practice, 2019
- Effect of Increased Enteral Protein Intake on Growth in Human Milk–Fed Preterm InfantsJAMA Pediatrics, 2017
- Effect of Supplemental Donor Human Milk Compared With Preterm Formula on Neurodevelopment of Very Low-Birth-Weight Infants at 18 MonthsJAMA, 2016
- Effect of Donor Milk on Severe Infections and Mortality in Very Low-Birth-Weight InfantsJAMA Pediatrics, 2016
- Calorie and protein-enriched formula versus standard term formula for improving growth and development in preterm or low birth weight infants following hospital discharge2005
- Growth and Phosphorus Metabolism in Premature Infants Fed Human Milk, Fortified Human Milk, or Special Premature FormulaAmerican Journal of Diseases of Children, 1987